MedTrace Logo

Is Biodentine, as Successful as, Mineral Trioxide Aggregate

NCT03686475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2018-09-27

No results posted yet for this study

Summary

: A split-mouth controlled clinical trial was carried out on 21 healthy, three to seven years old children, with 42 pairs (84 molars) of contralateral mandibular primary molars indicated for pulpotomy. One paired tooth in one side was designated to Biodentine (Group 1) and the other side for MTA (Group 2) as a pulp medicament. All pulpotomized teeth were finally restored with stainless steel crowns. Subjects were monitored clinically and radiographically at one, three, six and 12 months.

Conditions

  • Dental Caries

Interventions

OTHER

Biodentine

pulpotomy for primary molars , clinical and radiographic evaluation at 1,3,6 and 12month

OTHER

MTA pulpotomy

MTA pulpotomy

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Dr Randa Abd El Gawad · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-07-31
Completion
2017-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686475 on ClinicalTrials.gov